- Home
- OUST vs MNKD Comparison
OUST vs MNKD Comparison
Compare OUST & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUST
- MNKD
- Stock Information
- Founded
- OUST 2015
- MNKD 1991
- Country
- OUST United States
- MNKD United States
- Employees
- OUST N/A
- MNKD N/A
- Industry
- OUST Industrial Machinery/Components
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- OUST Technology
- MNKD Health Care
- Exchange
- OUST Nasdaq
- MNKD Nasdaq
- Market Cap
- OUST 1.1B
- MNKD 1.2B
- IPO Year
- OUST N/A
- MNKD 2004
- Fundamental
- Price
- OUST $28.66
- MNKD $5.40
- Analyst Decision
- OUST Strong Buy
- MNKD Strong Buy
- Analyst Count
- OUST 6
- MNKD 5
- Target Price
- OUST $23.83
- MNKD $10.80
- AVG Volume (30 Days)
- OUST 2.3M
- MNKD 5.5M
- Earning Date
- OUST 11-06-2025
- MNKD 11-06-2025
- Dividend Yield
- OUST N/A
- MNKD N/A
- EPS Growth
- OUST N/A
- MNKD 149.32
- EPS
- OUST N/A
- MNKD 0.11
- Revenue
- OUST $125,848,000.00
- MNKD $301,736,000.00
- Revenue This Year
- OUST $33.30
- MNKD $14.52
- Revenue Next Year
- OUST $36.50
- MNKD $12.81
- P/E Ratio
- OUST N/A
- MNKD $50.09
- Revenue Growth
- OUST 26.37
- MNKD 21.48
- 52 Week Low
- OUST $5.91
- MNKD $3.38
- 52 Week High
- OUST $36.25
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- OUST 50.59
- MNKD 66.40
- Support Level
- OUST $27.68
- MNKD $5.36
- Resistance Level
- OUST $31.10
- MNKD $5.68
- Average True Range (ATR)
- OUST 1.95
- MNKD 0.28
- MACD
- OUST -0.23
- MNKD 0.06
- Stochastic Oscillator
- OUST 35.01
- MNKD 67.21
About OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.